Mineralys Therapeutics (MLYS) Stock Chart & Stock Price History $16.01 -0.18 (-1.14%) Closing price 03:59 PM EasternExtended Trading$16.03 +0.02 (+0.15%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mineralys Therapeutics Stock Price Performance The Mineralys Therapeutics (MLYS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 18.56%, with a year-to-date return of 30.02%. In the past month, the stock has increased 9.26%, reflecting recent market activity. As of the latest close, Mineralys Therapeutics traded at $16.19 with a market cap of $1.06 billion and volume of 381,007 shares. Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.47%1 Month Performance+9.26%3 Month Performance+6.99%Year-To-Date Performance+30.02%1 Year Performance+18.56% MLYS Stock Chart for Tuesday, June, 10, 2025 MLYS Chart by TradingView Mineralys Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/09/2025$16.12$16.19+0.43%$16.30$15.71381,007 shs$1.06 billion06/06/2025$15.62$16.12+3.20%$16.21$15.63394,653 shs$1.05 billion06/05/2025$15.52$15.62+0.64%$15.93$15.27415,796 shs$1.02 billion06/04/2025$16.18$15.52-4.08%$16.43$15.43566,085 shs$1.01 billion06/03/2025$15.70$16.18+3.06%$16.24$15.49698,785 shs$1.05 billion06/02/2025$15.73$15.70-0.19%$16.07$15.26412,916 shs$1.02 billion05/30/2025$15.66$15.73+0.45%$15.89$14.751.16 million shs$1.03 billion05/29/2025$15.84$15.66-1.14%$16.11$15.65283,784 shs$1.02 billion05/28/2025$15.73$15.84+0.70%$16.07$15.61338,184 shs$1.03 billion05/27/2025$15.96$15.73-1.44%$16.90$15.45946,814 shs$1.03 billion Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/26/2025$15.96$15.96$16.68$15.86927,902 shs$1.04 billion05/23/2025$16.32$15.96-2.21%$16.68$15.86927,902 shs$1.04 billion05/22/2025$16.66$16.32-2.04%$16.77$15.98447,062 shs$1.06 billion05/21/2025$16.10$16.66+3.48%$16.75$15.77708,003 shs$1.09 billion05/20/2025$15.32$16.10+5.09%$16.78$15.092.21 million shs$1.05 billion05/19/2025$15.35$15.32-0.20%$15.74$15.04436,348 shs$998.48 million05/16/2025$15.36$15.35-0.07%$15.95$15.24779,188 shs$995.85 million05/15/2025$15.11$15.36+1.65%$15.49$14.581.33 million shs$996.50 million05/14/2025$15.19$15.11-0.53%$15.86$14.891.02 million shs$980.28 million05/13/2025$15.01$15.19+1.20%$15.81$14.741.63 million shs$985.47 million05/12/2025$14.65$15.01+2.46%$15.47$14.18876,144 shs$973.79 million05/09/2025$15.61$14.65-6.15%$15.94$14.40644,840 shs$950.43 million Related Companies MRUS Stock Chart RYTM Stock Chart AKRO Stock Chart RNA Stock Chart PTCT Stock Chart CYTK Stock Chart SRPT Stock Chart KRYS Stock Chart ACAD Stock Chart SWTX Stock Chart Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MLYS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s treachery This might just be the greatest time in America to be an energy company. Since taking office in 2025, Presi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLYS Stock Free MLYS Stock Alerts